HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$11.81
Day range
$11.52 - $12.85
Year range
$10.00 - $29.60
Market cap
57.84M USD
Avg Volume
100.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 17.58M | 72.06% |
Operating expense | 75.70M | 2,108.31% |
Net income | -5.61M | 58.05% |
Net profit margin | -31.91 | 75.62% |
Earnings per share | -0.80 | 78.95% |
EBITDA | -6.04M | 54.37% |
Effective tax rate | -1.15% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.78M | 9.31% |
Total assets | 67.03M | 40.84% |
Total liabilities | 75.24M | 49.00% |
Total equity | -8.21M | — |
Shares outstanding | 91.24M | — |
Price to book | -131.22 | — |
Return on assets | -23.27% | — |
Return on capital | -335.14% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.61M | 58.05% |
Cash from operations | -12.72M | 39.42% |
Cash from investing | -178.00K | -1,877.78% |
Cash from financing | 8.00K | -98.80% |
Net change in cash | -12.89M | 36.64% |
Free cash flow | 9.36M | 168.13% |
About
Founded
2012
Headquarters
Website
Employees
69